Stock Detail
Sector:
Latest Quote @ Sat May 5 06:38:11 (15 min delayed)
Last Day's Data
| $0.00 |
$0.00 |
$0.00 |
0.00% |
0.00 |
$0.00 |
| $0.00 |
$0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Stock Profile
Kensey Nash Corporation, a medical technology company, engages in the development and manufacture of absorbable biomaterials-based products with applications in the cardiology, orthopaedics, spine, drug and biologics delivery, periodontal/dental, surgical, and wound care markets. It primarily offers Angio-Seal vascular closure device, a device designed to seal and close femoral artery punctures made during diagnostic and therapeutic cardiovascular catheterizations; and TriActiv embolic protection system, a device designed to prevent microparticulate from traveling downstream during the treatment of diseased coronary saphenous vein bypass grafts. This system utilizes active flushing and extraction to remove debris from the vessel after a treatment procedure. The company also develops various bone graft substitutes fabricated from collagen, synthetic polymers, or composite biomaterials. Kensey Nash has a strategic alliance with St. Jude Medical, Inc. The company was founded in 1984 and is based in Exton, Pennsylvania.
